Alexander's, Inc.(ALX)Earnings, Financials & Key Ratios

SOUTH SAN FRANCISCO, Calif., June 30, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. ("ALX Oncology," Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients' lives, announced that the Compensation Committee of the Board of Directors of ALX Oncology approved the granting of an inducement stock option to purchase a total of 500,000 shares of ALX Oncology's common stock to Michael Listgarten, General Counsel, on June 29, 2026 in connection with the commencement of his employment. Mr. Listgarten's inducement stock option is subject to the terms of the ALX Oncology Holdings Inc. 2025 Inducement Equity Incentive Plan and related forms of agreements, and was granted as an inducement material to Mr. Listgarten to enter into employment with ALX Oncology in accordance with Nasdaq Listing Rule 5635(c)(4).

Strengthens Leadership with Veteran Executives with Decades of Industry Experience Scott Garland Succeeds Co-Founder Corey Goodman, Ph.D., After More Than a Decade of Foundational Leadership SOUTH SAN FRANCISCO, Calif.

PARAMUS, N. J. , June 29, 2026 (GLOBE NEWSWIRE) -- Alexander's, Inc. (NYSE: ALX) announced today that it has completed a 15-year lease (with renewal options) with Target Corporation at its Rego Park Shopping Center located on Junction Blvd at the Long Island Expressway, in the middle of densely populated Queens, New York.

PARAMUS, N.J., June 29, 2026 (GLOBE NEWSWIRE) -- Alexander's, Inc. (NYSE: ALX) announced today that it has completed a 15-year lease (with renewal options) with Target Corporation at its Rego Park Shopping Center located on Junction Blvd at the Long Island Expressway, in the middle of densely populated Queens, New York.

VANCOUVER, British Columbia, June 16, 2026 (GLOBE NEWSWIRE) -- Greenridge Exploration Inc. (“Greenridge” or the “Company”) (CSE: GXP | OTC: GXPLF | FRA: HW3), is pleased to announce that the Company has fulfilled all the obligations of its property option agreement (the “Agreement”) to earn a 100% legal and beneficial interest in the Carpenter Lake Uranium Project (“Carpenter Lake” or the “Project”), located on the southern margin of the Athabasca Basin in northern Saskatchewan, Canada. Greenridge entered into the Agreement in May 2024 with ALX Resources Corp. (“ALX”) and Renegade Gold Inc. (“Renegade” and together with ALX, the “Optionors”) and has since carried out systematic exploration at the Project, including diamond drilling, in 2024, 2025 and 2026.